<ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>
    歡迎來到上海通蔚!

    021-54845833/15800441009

    品質(zhì)保證 · 通蔚試劑

    當前位置: 首頁 > 科研產(chǎn)品 > 科研抗體 > 一抗 > 兔抗ABHD12多克隆抗體

    產(chǎn)品中心

    最新產(chǎn)品

    • 兔抗ABHD12多克隆抗體

      規(guī)格:
      價格:
      • 品牌 : 通蔚生物
      • 目錄號 : TW1008
      • 應(yīng)用 : 僅用于科研使用
      • 貨期 : 現(xiàn)貨
      • 規(guī)格 :100ul/200ul/25ul
    • 商品詳情
    • 參考文獻
    • 說明書下載
    • 商品評論0
    • 相關(guān)產(chǎn)品

    中文名稱: 兔抗ABHD12多克隆抗體

    英文名稱: Anti-ABHD12 rabbit polyclonal antibody

    別      名: PHARC; ABHD12A; BEM46L2; C20orf22; dJ965G21.2

    儲      存: 冷凍(-20℃)

    抗      原: ABHD12

    宿      主: Rabbit

    相關(guān)類別: 一抗

    反應(yīng)種屬:
    Human, Mouse, Rat

    記 物:Unconjugate

    克隆類型: rabbit polyclonal

    技術(shù)規(guī)格

    Background:

    This gene encodes an enzyme that catalyzes the hydrolysis of 2-arachidonoyl glycerol (2-AG), the main endocannabinoid lipid transmitter that acts on cannabinoid receptors, CB1 and CB2. The endocannabinoid system is involved in a wide range of physiological processes, including neurotransmission, mood, appetite, pain appreciation, addiction behavior, and inflammation. Mutations in this gene are associated with the neurodegenerative disease, PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract), resulting from an inborn error of endocannabinoid metabolism. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.

    Applications:

    ELISA, IHC

    Name of antibody:

    ABHD12

    Immunogen:

    Fusion protein of human ABHD12

    Full name:

    abhydrolase domain containing 12

    Synonyms:

    PHARC; ABHD12A; BEM46L2; C20orf22; dJ965G21.2

    SwissProt:

    Q8N2K0

    ELISA Recommended dilution:

    2000-5000

    IHC positive control:

    Human thyroid cancer and human liver cancer

    IHC Recommend dilution:

    25-100





    產(chǎn)品掃碼查看詳情
    手機掃描查看
    <ul id="eack0"><dfn id="eack0"></dfn></ul>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><input id="eack0"></input></strike>
    
    
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"><menu id="eack0"></menu></strike>
  • <strike id="eack0"></strike>